1. Home
  2. GMED vs DVA Comparison

GMED vs DVA Comparison

Compare GMED & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • DVA
  • Stock Information
  • Founded
  • GMED 2003
  • DVA 1994
  • Country
  • GMED United States
  • DVA United States
  • Employees
  • GMED N/A
  • DVA N/A
  • Industry
  • GMED Medical/Dental Instruments
  • DVA Misc Health and Biotechnology Services
  • Sector
  • GMED Health Care
  • DVA Health Care
  • Exchange
  • GMED Nasdaq
  • DVA Nasdaq
  • Market Cap
  • GMED 9.6B
  • DVA 10.9B
  • IPO Year
  • GMED 2012
  • DVA 1995
  • Fundamental
  • Price
  • GMED $59.22
  • DVA $136.18
  • Analyst Decision
  • GMED Buy
  • DVA Hold
  • Analyst Count
  • GMED 13
  • DVA 4
  • Target Price
  • GMED $94.30
  • DVA $157.00
  • AVG Volume (30 Days)
  • GMED 2.2M
  • DVA 828.5K
  • Earning Date
  • GMED 05-08-2025
  • DVA 05-12-2025
  • Dividend Yield
  • GMED N/A
  • DVA N/A
  • EPS Growth
  • GMED 145.70
  • DVA 14.90
  • EPS
  • GMED 1.34
  • DVA 10.11
  • Revenue
  • GMED $2,510,810,000.00
  • DVA $12,968,524,000.00
  • Revenue This Year
  • GMED $14.43
  • DVA $6.00
  • Revenue Next Year
  • GMED $9.40
  • DVA $3.66
  • P/E Ratio
  • GMED $44.30
  • DVA $13.48
  • Revenue Growth
  • GMED 32.26
  • DVA 5.11
  • 52 Week Low
  • GMED $54.48
  • DVA $131.76
  • 52 Week High
  • GMED $94.93
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • GMED 37.49
  • DVA 37.73
  • Support Level
  • GMED $57.14
  • DVA $136.50
  • Resistance Level
  • GMED $60.10
  • DVA $140.42
  • Average True Range (ATR)
  • GMED 1.58
  • DVA 3.66
  • MACD
  • GMED 0.16
  • DVA -0.59
  • Stochastic Oscillator
  • GMED 49.90
  • DVA 11.71

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: